Clinical Trial Update: PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating prasugrel monotherapy after primary PCI in ST-segment Elevation Myocardial Infarction (STEMI) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

Sponsor: Kindai University | Conditions: ST-segment Elevation Myocardial Infarction (STEMI) | Phase 4 | Status: RECRUITING